- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 275302, 9 pages
Role of PIR-B in Autoimmune Glomerulonephritis
Department of Experimental Immunology, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo, Sendai 980-8575, Japan
Received 28 July 2010; Accepted 7 September 2010
Academic Editor: Monica Fedele
Copyright © 2011 Toshiyuki Takai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citations to this Article [4 citations]
The following is the list of published articles that have cited the current article.
- Keri L. Nowend, Alison N. Starr-Moss, and Keith E. Murphy, “The function of dog models in developing gene therapy strategies for human health,” Mammalian Genome, vol. 22, no. 7-8, pp. 476–485, 2011.
- Junke Zheng, Masato Umikawa, Changhao Cui, Jiyuan Li, Xiaoli Chen, Chaozheng Zhang, HoangDinh Hyunh, Xunlei Kang, Robert Silvany, Xuan Wan, Jingxiao Ye, Alberto Puig Canto, Shu-Hsia Chen, Huan-You Wang, E. Sally Ward, and Cheng Cheng Zhang, “Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemi a development,” Nature, vol. 485, no. 7400, pp. 656–+, 2012.
- N. Sieger, S. J. Fleischer, H. E. Mei, K. Reiter, A. Shock, G. R. Burmester, C. Daridon, and T. Dörner, “ CD22 ligation inhibits downstream B cell receptor signaling and Ca 2+ flux upon activation ,” Arthritis & Rheumatism, vol. 65, no. 3, pp. 770–779, 2013.
- Zhaoyu Gou, Yajing Mi, Fengliang Jiang, Bin Deng, Jun Yang, and Xingchun Gou, “PirB is a novel potential therapeutic target for enhancing axonal regeneration and synaptic plasticity following CNS injury in mammals,” Journal of Drug Targeting, pp. 1–7, 2014.